Chronic administration of caderofloxacin, a new fluoroquinolone, increases hepatic CYP2E1 expression and activity in rats

Acta Pharmacologica Sinica
Li LiuXiao-Dong Liu

Abstract

Caderofloxacin is a new fluoroquinolone that is under phase III clinical trials in China. Here we examined the effects of caderofloxacin on rat hepatic cytochrome P450 (CYP450) isoforms as well as the potential of caderofloxacin interacting with co-administered drugs. Male rats were treated with caderofloxacin (9 mg/kg, ig) once or twice daily for 14 consecutive days. The effects of caderofloxacin on CYP3A, 2D6, 2C19, 1A2, 2E1 and 2C9 were evaluated using a "cocktail" of 6 probes (midazolam, dextromethorphan, omeprazole, theophylline, chlorzoxazone and diclofenac) injected on d 0 (prior to caderofloxacin exposure) and d 15 (after caderofloxacin exposure). Hepatic microsomes from the caderofloxacin-treated rats were used to assess CYP2E1 activity and chlorzoxazone metabolism. The expression of CYP2E1 mRNA and protein in hepatic microsomes was analyzed with RT-PCR and Western blotting, respectively. Fourteen-day administration of caderofloxacin significantly increased the activity of hepatic CYP2E1, leading to enhanced metabolism of chlorzoxazone. In vitro microsomal study confirmed that CYP2E1 was a major metabolic enzyme involved in chlorzoxazone metabolism, and the 14-d administration of caderofloxacin significantly increased ...Continue Reading

References

Oct 1, 1995·Antimicrobial Agents and Chemotherapy·D J BiedenbachR N Jones
May 1, 1996·Antimicrobial Agents and Chemotherapy·N MasudaT Nishino
Jun 1, 2000·Infectious Disease Clinics of North America·J A O'Donnell, S P Gelone
Aug 10, 2002·Journal of Cellular and Molecular Medicine·R ZuberP Anzenbacher
Jun 15, 2004·Biochemical Pharmacology·Theresa C PetersonFrank J Gonzalez
Oct 13, 2006·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Emel ArinçOrhan Adali
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Marcella MartignoniRuben de Kanter
Jan 30, 2007·Clinical Pharmacology and Therapeutics·S-M HuangL J Lesko
Sep 10, 2008·European Journal of Drug Metabolism and Pharmacokinetics·Mei-Juan XuTian Lv
Dec 17, 2009·British Journal of Clinical Pharmacology·Sandrine TurpaultXavier Boulenc
Mar 9, 2010·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Kuresh A Youdim, Kenneth C Saunders
Mar 2, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Eric S OrmanUNKNOWN DILIN Research Group
Nov 15, 2011·The American Journal of Geriatric Pharmacotherapy·Lisa E Hines, John E Murphy
Feb 7, 2012·Drug Discovery Today·Bernard TestaGiulio Vistoli
Aug 7, 2012·Molecular Nutrition & Food Research·Carolin NeuwirthAngela Mally
Dec 20, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Thamir M AlshammariKerry L LaPlante
Jun 5, 2014·Analytical and Bioanalytical Chemistry·Dany SpaggiariSerge Rudaz
Jun 15, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Ana Carolina Valencia-OlveraJesús Javier Espinosa-Aguirre
Jul 17, 2014·European Journal of Clinical Pharmacology·Ben D SnyderMatthew P Doogue
Aug 20, 2014·BMC Complementary and Alternative Medicine·Jingjing YanChunhuan Jin

❮ Previous
Next ❯

Citations

May 22, 2016·The International Journal of Biochemistry & Cell Biology·Zainab SafiedeenM Carmen Martinez
May 4, 2018·European Journal of Drug Metabolism and Pharmacokinetics·Jing SunWeidong Chen
Oct 18, 2019·Nutrients·Hsien-Tsung YaoWenchang Chiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.